Share this short myth-busting video with your vaccine-hesitant patients.
A member of the ACR COVID-19 Vaccine Clinical Guidance Task Force provides an update on the latest data.
Healthcare providers should frame patient concerns in the context of the seriousness of the pandemic.
Many cases of cerebral venous sinus thrombosis start with a dull, pounding headache that turns severe. A stroke specialist shares other symptoms plus management advice in recipients of Johnson & Johnson’s COVID-19 vaccine.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
People with multiple sclerosis fare about as well as other populations following SARS-CoV-2 infection, but ambulation disability and a few other factors raise the risk of a worse clinical course.
Technology-driven automation has ensured that Cleveland Clinic is able to vaccinate as many people as possible all while navigating a difficult landscape.
In addition to producing potent neutralizing antibodies, the candidate vaccine may not require strict temperature control. Progress toward human studies continues.
A small, but not insignificant number of people develop unilateral axillary adenopathy in the days following vaccination against SARS-CoV-2, the virus that causes COVID-19. Diagnostic radiologist Laura Dean, MD, explains that these nodes can be palpable and visible on screening mammograms. Follow-up is required, but the condition is often a natural immune response that resolves on its own.
A hematologist/oncologist offers context for patients who might be hesitant to receive the COVID-19 vaccine.
Historical disparities and distrust of institutions can’t be fixed overnight, but when it comes to addressing vaccine hesitancy among minorities and low-income populations, Dr. Lee Kirksey believes in transparency and patient-empowering communications.